- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05714163
Effects of Ai Chi on Scapular Muscle Activation in Overhead Athletes With Scapular Dyskinesis
January 13, 2026 updated by: National Taiwan University Hospital
Scapular dyskinesis (SD) is common in overhead athletes and negatively influence the athletes' performance, increasing the risk of shoulder injury.
The kinetic chain (KC) exercises for SD rehabilitation that emphasize importance of core strength and scapula stability during skillful performance.
Ai Chi, the aquatic exercises performed in functional positions, which are adequate for power transfer of KC.
This study will investigate the effect of KC-based water exercises, Ai Chi, on scapular muscles in overhead athletes with SD.
Study Overview
Status
Completed
Detailed Description
The purpose of this study is to investigate muscle activations of the upper trapezius (UT), lower trapezius (LT), serratus anterior (SA), latissimus dorsi (LD), and muscle balance ratios of UT/LT, UT/SA I in overhead athletes with SD via KC-based exercise in water and on land.
KC-based exercises including the movement patterns of Ai Chi which consist of shoulder flexion/ extension, horizontal abduction/ adduction, internal and external rotation, scapular protraction/retraction combined with spinal rotation.
Study Type
Observational
Enrollment (Actual)
21
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The participants are overhead athletes with scapular dyskinesis (SD) who played overhead sports activities at least 3 hours/week.
Description
Inclusion Criteria:
- The participants are overhead athletes with scapular dyskinesis (SD) who played overhead sports activities at least 3 hours/week.
Exclusion Criteria:
- the individuals who have shoulder/neck pain in recent 3 months (VAS >7/10)
- severe shoulder trauma (the collision shoulder, shoulder sprains or strains)
- severe scoliosis (Cobb angle > 25 degrees)
- surgery of upper extremity (the shoulder, cervical spine and elbow) or cervical spine
- peripheral nerve injury or neurological disease (impaired sensation or motor function: numbness, tingle, muscle weakness)
- body mass index (BMI) >25
- infectious disease (upper respiratory tract infection, skin infection, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of maximal voluntary isometric contraction of upper trapezius (UT), lower trapezius (LT), serratus anterior (SA), latissimus dorsi (LD)
Time Frame: Through study completion, an average of 10 months
|
The muscle activity of UT, LT, SA and LD of the dominant hand will be recorded for 3 trials of each exercises with 3-seconds concentric phase and 3-seconds eccentric phase.
There is a 3-second rest between trails and one-minute rest between exercises.
|
Through study completion, an average of 10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle balance ratio of UT/SA
Time Frame: Through study completion, an average of 10 months
|
The muscle balance ratio will be calculated to represent the conditions of these force couples in scapular region.
|
Through study completion, an average of 10 months
|
|
Muscle balance ratio of UT/LT
Time Frame: Through study completion, an average of 10 months
|
The muscle balance ratio will be calculated to represent the conditions of these force couples in scapular region.
|
Through study completion, an average of 10 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jiu-Jenq Lin, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 16, 2022
Primary Completion (Actual)
February 23, 2023
Study Completion (Actual)
February 23, 2023
Study Registration Dates
First Submitted
October 12, 2022
First Submitted That Met QC Criteria
January 26, 2023
First Posted (Actual)
February 6, 2023
Study Record Updates
Last Update Posted (Actual)
January 15, 2026
Last Update Submitted That Met QC Criteria
January 13, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Musculoskeletal Diseases
- Nervous System Diseases
- Muscular Diseases
- Neuromuscular Manifestations
- Wounds and Injuries
- Pathologic Processes
- Sprains and Strains
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Muscle Weakness
- Athletic Injuries
- Cumulative Trauma Disorders
Other Study ID Numbers
- 202208053RINA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.